Referensi Tuberkulosis A-B

1. Abbas, U., Masood, K.I., Khan, A., Irfan, M., Saifullah, N., Jamil, B. and Hasan, Z., 2022. Tuberculosis and diabetes mellitus: Relating immune impact of co-morbidity with challenges in disease management in high burden countries. Journal of clinical tuberculosis and other mycobacterial diseases, 29, p.100343.
2. Abdullahi, L.H., Oketch, S., Komen, H., Mbithi, I., Millington, K., Mulupi, S., Chakaya, J. and Zulu, E.M., 2024. Gendered gaps to tuberculosis prevention and care in Kenya: a political economy analysis study. BMJ open, 14(4), p.e077989.
3. Adam, N., Pallikadavath, S., Cerasuolo, M. and Amos, M., 2021. Investigating the risk factors for contraction and diagnosis of human tuberculosis in Indonesia using data from the fifth wave of RAND’s Indonesian Family Life Survey (IFLS-5). Journal of Biosocial Science, 53(4), pp.577-589.
4. Adane, H.T., Howe, R.C., Wassie, L. and Magee, M.J., 2023. Diabetes mellitus is associated with an increased risk of unsuccessful treatment outcomes among drug-susceptible tuberculosis patients in Ethiopia: A prospective health facility-based study. Journal of Clinical Tuberculosis and Other Mycobacterial Diseases, 31, p.100368.
5. Adebayo, B.I., Adejumo, O.A. and Odusanya, O.O., 2024. Health-related quality of life among adults newly diagnosed with pulmonary tuberculosis in Lagos State, Nigeria: A prospective study. Quality of life research, 33(1), pp.157-168.
6. Ajudua, F.I. and Mash, R.J., 2024. Implementing active surveillance for TB: A descriptive survey of healthcare workers in the Eastern Cape, South Africa. African Journal of Primary Health Care & Family Medicine, 16(1), p.4217.
7. Akinshipe, B.O., Yusuf, E.O., Akinshipe, F.O., Moronkeji, M.A. and Nwaobi, A.C., 2019. Prevalence and Determinants of Pre-diabetes and Latent Tuberculosis Infection Among Apparently Healthy Adults in Three Communities in Southern Nigeria. International Journal of Immunology, 7(2), pp.23-32.
8. Al-Bari MAA, Peake N, Eid N. Tuberculosis-diabetes comorbidities: Mechanistic insights for clinical considerations and treatment challenges. World J Diabetes 2024; 15(5): 853-866.
9. Alemu, A., Diriba, G., Seid, G., Wondimu, A., Moga, S., Tadesse, G., Haile, B., Berhe, N., Mariam, S.H. and Gumi, B., 2025. Active tuberculosis among patients with presumptive tuberculosis with chronic kidney disease in a high tuberculosis burden country, Ethiopia: a multi-center study. IJID regions, 14, p.100551.
10. Alemu, A., Seid, G., Diriba, G., Hailu, M., Dange, B., Moga, S., Melese, D., Tadesse, G., Mariam, S.H., Berhe, N. and Gumi, B., 2025. Prevalence and associated factors of tuberculosis among diabetic patients attending public health facilities in Ethiopia: a multicenter study. Archives of Public Health, 83(1), pp.1-15.
11. Alisjahbana, B., Sahiratmadja, E., Nelwan, E.J., Purwa, A.M., Ahmad, Y., Ottenhoff, T.H., Nelwan, R.H., Parwati, I., Meer, J.W.V.D. and Crevel, R.V., 2007. The effect of type 2 diabetes mellitus on the presentation and treatment response of pulmonary tuberculosis. Clinical infectious diseases, 45(4), pp.428-435.
12. Alma, L.R., Olivionita, V. and Wardani, H.E., 2024. An Ecological Study of Determinants of The Incidence of Tuberculosis in Malang Raya Area. Preventia: The Indonesian Journal of Public Health, 9(1), 112–120.
13. Almeida-Junior JL, Gil-Santana L, Oliveira CAM, Castro S, Cafezeiro AS, Daltro C, et al. (2016) Glucose Metabolism Disorder Is Associated with Pulmonary Tuberculosis in Individuals with Respiratory Symptoms from Brazil. PLoS ONE 11(4):e0153590.
14. Alvarado-Valdivia, N.T., Flores, J.A., Inolopú, J.L. and Rosales-Rimache, J.A., 2024. Type 2 diabetes mellitus and recurrent Tuberculosis: A retrospective cohort in Peruvian military workers. Journal of Clinical Tuberculosis and Other Mycobacterial Diseases, 35, p.100432.
15. Amelia, G. and Suryanto, J., 2024. Sensitivity Analysis of Diabetes Mellitus and Tuberculosis for Confounders: A Comprehensive Systematic Review. The Indonesian Journal of General Medicine, 1(1), pp.28-45.
16. Antonio-Arques, V., Caylà, J.A., Real, J., Moreno-Martinez, A., Orcau, À., Mauricio, D., Mata-Cases, M., Julve, J., Navas Mendez, E., Puig Treserra, R. and Millet, J.P., 2022. Glycemic control and the risk of tuberculosis in patients with diabetes: A cohort study in a Mediterranean city. Frontiers in public health, 10, p.1017024.
17. Araia, Z.Z., Mesfin, A.B., Mebrahtu, A.H., Tewelde, A.G., Osman, R. and Tuumzghi, H.A., 2021. Diabetes mellitus and its associated factors in tuberculosis patients in maekel region, eritrea: analytical cross-sectional study. Diabetes, Metabolic Syndrome and Obesity, pp.515-523.
18. Araujo-Pereira, M., Vinhaes, C.L., Barreto-Duarte, B., Villalva-Serra, K., Queiroz, A.T.L., & Andrade, B.B. (2024). Intersecting epidemics: Deciphering the complexities of tuberculosis-diabetes comorbidity. Frontiers in Tuberculosis, 2, Article 1487793. 
19. Aravindhan, V. and Yuvaraj, S., 2024. Immune-endocrine network in diabetes-tuberculosis nexus: does latent tuberculosis infection confer protection against meta-inflammation and insulin resistance?. Frontiers in Endocrinology, 15, p.1303338.
20. Arriaga, M.B., Araújo-Pereira, M., Barreto-Duarte, B., Nogueira, B., Freire, M.V.C., Queiroz, A.T., Rodrigues, M.M., Rocha, M.S., Souza, A.B., Spener-Gomes, R. and Carvalho, A.C.C., 2022. The effect of diabetes and prediabetes on antituberculosis treatment outcomes: a multicenter prospective cohort study. The Journal of Infectious Diseases, 225(4), pp.617-626.
21. Arriaga, M.B., Rocha, M.S., Nogueira, B.M., Nascimento, V., Araújo-Pereira, M., Souza, A.B., Andrade, A.M., Costa, A.G., Gomes-Silva, A., Silva, E.C. and Figueiredo, M.C., 2021. The effect of diabetes and prediabetes on Mycobacterium tuberculosis transmission to close contacts. The Journal of Infectious Diseases, 224(12), pp.2064-2072.
22. Baik, Y., Rickman, H.M., Hanrahan, C.F., Mmolawa, L., Kitonsa, P.J., Sewelana, T., Nalutaaya, A., Kendall, E.A., Lebina, L., Martinson, N. and Katamba, A., 2020. A clinical score for identifying active tuberculosis while awaiting microbiological results: development and validation of a multivariable prediction model in sub-Saharan Africa. PLoS medicine, 17(11), p.e1003420.
23. Baker, M.A., Lin, H.H., Chang, H.Y. and Murray, M.B., 2012. The risk of tuberculosis disease among persons with diabetes mellitus: a prospective cohort study. Clinical Infectious Diseases, 54(6), pp.818-825.
24. Bao, J., Hafner, R., Lin, Y., Lin, H.H. and Magee, M.J., 2018. Curbing the tuberculosis and diabetes co-epidemic: strategies for the integration of clinical care and research. The International Journal of Tuberculosis and Lung Disease, 22(10), pp.1111-1112.
25. Barberis, I., Bragazzi, N.L., Galluzzo, L. and Martini, M., 2017. The history of tuberculosis: from the first historical records to the isolation of Koch’s bacillus. Journal of Preventive Medicine and Hygiene, 58(1), pp.E9-E12.
26. Barron, M.M., Shaw, K.M., Bullard, K.M., Ali, M.K. and Magee, M.J., 2018. Diabetes is associated with increased prevalence of latent tuberculosis infection: Findings from the National Health and Nutrition Examination Survey, 2011–2012. Diabetes research and clinical practice, 139, pp.366-379.
27. Basham CA, Karim ME, Cook VJ, Patrick DM, Johnston JC. Post-tuberculosis mortality risk among immigrants to British Columbia, Canada, 1985–2015: a time-dependent Cox regression analysis of linked immigration, public health, and vital statistics data. Canadian Journal of Public Health. 2021 Feb;112(1):132-41.
28. Basham CA, Smith SJ, Romanowski K, Johnston JC (2020). Cardiovascular morbidity and mortality among persons diagnosed with tuberculosis: A systematic review and meta-analysis. PLoS ONE, 15(7), e0235821.
29. Bezerra, A.L., Moreira, A.D.S.R., Isidoro-Gonçalves, L., Lara, C.F.D.S., Amorim, G., Silva, E.C., Kritski, A.L. and Carvalho, A.C.C., 2022. Clinical, laboratory, and radiographic aspects of patients with pulmonary tuberculosis and dysglycemia and tuberculosis treatment outcomes. Jornal Brasileiro de Pneumologia, 48(06), p.e20210505.
30. Bhatia, V., Rijal, S., Sharma, M., Islam, A., Vassall, A., Bhargava, A., Thida, A., Basri, C., Onozaki, I., Pai, M. and Rezwan, M.K., 2023. Ending TB in South-East Asia: flagship priority and response transformation. The Lancet Regional Health-Southeast Asia, 18.
31. Bhatia V, Srivastava R, Reddy KS, et al. Ending TB in Southeast Asia: current resources are not enough. BMJ Global Health 2020;5:e002073. doi:10.1136/ bmjgh-2019-002073.
32. Bian, Q., Zhang, Y., Xue, C., Lu, W., Li, W., Pan, F. and Li, Y., 2024. Global and regional estimates of tuberculosis burden attributed to high fasting plasma glucose from 1990 to 2019: emphasis on earlier glycemic control. BMC Public Health, 24(1), p.782.
33. Bigio, J., Viscardi, A., Gore, G., Matteelli, A. and Sulis, G., 2023. A scoping review on the risk of tuberculosis in specific population groups: can we expand the World Health Organization recommendations?. European Respiratory Review, 32(167).
34. Bisht MK, Dahiya P, Ghosh S and Mukhopadhyay S (2023) The cause-effect relation of tuberculosis on incidence of diabetes mellitus. Front. Cell. Infect. Microbiol.
35. Boadu, A.A., Yeboah-Manu, M., Osei-Wusu, S. and Yeboah-Manu, D., 2024. Tuberculosis and diabetes mellitus: The complexity of the comorbid interactions. International Journal of Infectious Diseases, p.107140.
36. Brake, J., Ajie, M., Sumpter, N.A., Koesoemadinata, R.C., Soetedjo, N.N., Santoso, P., Alisjahbana, B., Ruslami, R., Hill, P. and van Crevel, R., 2025. Inflammation and dyslipidaemia in combined diabetes and tuberculosis; a cohort study. iScience, 28(6).
37. Brooks, M.B., Lecca, L., Becerra, M.C., Calderon, R.I., Contreras, C.C., Jimenez, J., Yataco, R.M., Zhang, Z., Murray, M.B. and Huang, C.C., 2025. The Role of Youths in Within-Household Tuberculosis Transmission: A Household Contact Cohort Study. Clinical Infectious Diseases, p.ciaf490.
38. Buasroung, P., Petnak, T., Liwtanakitpipat, P. and Kiertiburanakul, S., 2022. Prevalence of diabetes mellitus in patients with tuberculosis: a prospective cohort study. International Journal of Infectious Diseases, 116, pp.374-379.
39. Bumbu, L., Vaccher, S., Holmes, A., Sodeng, K., Graham, S.M. and Lin, Y.D., 2024. Drug-resistant TB in Morobe Province, Papua New Guinea, 2012–2021. Public Health Action, 14(4), pp.146-151.
40. Buryanti, S., 2021. Faktor-Faktor yang Mempengaruhi Kejadian TB MDR di Kota Semarang. Journal Health & Science: Gorontalo Journal Health and Science Community, 5(1), pp.146-154.
41. Byers, M.; Guy, E. The Complex Relationship Between Tuberculosis and Hyperglycemia. Diagnostics 2024, 14, 2539.

Referensi Tuberkulosis L

1. Lai, T.C., Chiang, C.Y., Wu, C.F., Yang, S.L., Liu, D.P., Chan, C.C. and Lin, H.H., 2016. Ambient air pollution and risk of tuberculosis: a cohort study. Occupational and environmental medicine, 73(1), pp.56-61.
2. Laili, F., Ronoatmodjo, S. and Murtiani, F., 2024. Ko-Infeksi TB-HIV terhadap Kegagalan Pengobatan Pasien Tuberkulosis Resistan Obat di Indonesia. The Indonesian Journal of Infectious Diseases, 10(2), pp.153-165.
3. Lam WJ, Chan KK, Wang G, Lai CK, Kang G, Chan C, Leung AC, Wong NH, Tso CS, Chow KM, Ramakrishnan S. Sequencing of Pleural Fluid and Plasma for Tuberculous Pleuritis. NEJM evidence. 2026 Mar 24;5(4):EVIDoa2500237.
4. Langley, I., Doulla, B., Lin, H.H., Millington, K. and Squire, B., 2012. Modelling the impacts of new diagnostic tools for tuberculosis in developing countries to enhance policy decisions. Health care management science, 15, pp.239-253.
5. Langley, I., Lin, H.H., Egwaga, S., Doulla, B., Ku, C.C., Murray, M., Cohen, T. and Squire, S.B., 2014. Assessment of the patient, health system, and population effects of Xpert MTB/RIF and alternative diagnostics for tuberculosis in Tanzania: an integrated modelling approach. The Lancet Global Health, 2(10), pp.e581-e591.
6. Lee C-H, Lee M-C, Lin H-H, Shu C-C, Wang J-Y, et al. (2012) Pulmonary Tuberculosis and Delay in Anti-Tuberculous Treatment Are Important Risk Factors for Chronic Obstructive Pulmonary Disease. PLoS ONE 7(5): e37978.
7. Lee, P.H., Lin, H.C., Huang, A.S.E., Wei, S.H., Lai, M.S. and Lin, H.H., 2014. Diabetes and risk of tuberculosis relapse: nationwide nested case-control study. PloS one, 9(3), p.e92623.
8. Lee P-H, Fu H, Lai T-C, Chiang C-Y, Chan C-C, Lin H-H (2016) Glycemic Control and the Risk of Tuberculosis: A Cohort Study. PLoS Med 13(8): e1002072.
9. Lee, E.H., Lee, J.M., Kang, Y.A., Leem, A.Y., Kim, E.Y., Jung, J.Y., Park, M.S., Kim, Y.S., Kim, S.K., Chang, J. and Kim, S.Y., 2017. Prevalence and impact of diabetes mellitus among patients with active pulmonary tuberculosis in South Korea. Lung, 195, pp.209-215.
10. Lee, M.R., Huang, Y.P., Kuo, Y.T., Luo, C.H., Shih, Y.J., Shu, C.C., Wang, J.Y., Ko, J.C., Yu, C.J. and Lin, H.H., 2017. Diabetes mellitus and latent tuberculosis infection: a systemic review and metaanalysis. Clinical Infectious Diseases, 64(6), pp.719-727.
11. Lee, P.H., Fu, H., Lee, M.R., Magee, M. and Lin, H.H., 2018. Tuberculosis and diabetes in low and moderate tuberculosis incidence countries. The International Journal of Tuberculosis and Lung Disease, 22(1), pp.7-16.
12. Lee, M.R., Keng, L.T., Lee, M.C., Chen, J.H., Lee, C.H. and Wang, J.Y., 2024. Impact of isoniazid monoresistance on overall and vulnerable patient populations in Taiwan. Emerging Microbes & Infections, 13(1), p.2417855.
13. Lee, C.S., Ho, C.H., Liao, K.M., Wu, Y.C. and Shu, C.C., 2025. The impacts of SGLT2 inhibitors on the mortality of patients with tuberculosis. Journal of Infection and Public Health, p.102686.
14. Lestari, H., 2024. Analisis Epidemiologi Kejadian Tuberkulosis Di Provinsi Sulawesi Tenggara Tahun 2021-2023. Variable Research Journal, 1(02), pp.802-810.
15. Lestari, B.W., Nijman, G., Larasmanah, A., Soeroto, A.Y., Santoso, P., Alisjahbana, B., Chaidir, L., Andriyoko, B., Van Crevel, R. and Hill, P.C., 2024. Management of drug-resistant tuberculosis in Indonesia: a four-year cascade of care analysis. The Lancet Regional Health-Southeast Asia, 22:100294.
16. Li, H., Chee, C.B., Geng, T., Pan, A. and Koh, W.P., 2022. Joint associations of multiple lifestyle factors with risk of active tuberculosis in the population: the Singapore Chinese Health Study. Clinical Infectious Diseases, 75(2), pp.213-220.
17. Li, Z., Liu, Q., Chen, L., Zhou, L., Qi, W., Wang, C., Zhang, Y., Tao, B., Zhu, L., Martinez, L. and Lu, W., 2024. Ambient air pollution contributed to pulmonary tuberculosis in China. Emerging Microbes & Infections, 13(1), p.2399275.
18. Li, J., Zhao, Y., Jiang, Y., Zhang, Y., Zhang, P., Shen, L. and Chen, Z., 2024. Prevalence and risk factors of diabetes in patients with active pulmonary tuberculosis: a cross-sectional study in two financially affluent China cities. Diabetes, Metabolic Syndrome and Obesity, pp.1105-1114.
19. Liang, L. and Su, Q., 2024. Prediabetes and the treatment outcome of tuberculosis: A meta‐analysis. Tropical Medicine & International Health, 29(9), pp.757-767.
20. Lin, H.H., Murray, M., Cohen, T., Colijn, C. and Ezzati, M., 2008. Effects of smoking and solid-fuel use on COPD, lung cancer, and tuberculosis in China: a time-based, multiple risk factor, modelling study. The Lancet, 372(9648), pp.1473-1483.
21. Lin, H.H., Ezzati, M., Chang, H.Y. and Murray, M., 2009. Association between tobacco smoking and active tuberculosis in Taiwan: prospective cohort study. American journal of respiratory and critical care medicine, 180(5), pp.475-480.
22. Lin, H.H., Langley, I., Mwenda, R., Doulla, B., Egwaga, S., Millington, K.A., Mann, G.H., Murray, M., Squire, S.B. and Cohen, T., 2011. A modelling framework to support the selection and implementation of new tuberculosis diagnostic tools. The International journal of tuberculosis and lung disease, 15(8), pp.996-1004.
23. Lin, H., Shin, S., Blaya, J.A., Zhang, Z., Cegielski, P., Contreras, C., Asencios, L., Bonilla, C., Bayona, J., Paciorek, C.J. and Cohen, T., 2011. Assessing spatiotemporal patterns of multidrug-resistant and drug-sensitive tuberculosis in a South American setting. Epidemiology & Infection, 139(11), pp.1784-1793.
24. Lin, H.H., Dowdy, D., Dye, C., Murray, M. and Cohen, T., 2012. The impact of new tuberculosis diagnostics on transmission: why context matters. Bulletin of the World Health Organization, 90, pp.739-747.
25. Lin HH, Shin SS, Contreras C, Asencios L, Paciorek CJ, Cohen T. Use of spatial information to predict multidrug resistance in tuberculosis patients, Peru. Emerg Infect Dis. 2012 May;18(5):811-3. doi: 10.3201/eid1805.111467.
26. Lin, H.H., Chiang, Y.T., Chuang, J.H., Yang, S.L., Chang, H.Y., Ezzati, M. and Murray, M., 2013. Exposure to secondhand smoke and risk of tuberculosis: prospective cohort study. PloS one, 8(10), p.e77333.
27. Lin, H.H., Suk, C.W., Lo, H.L., Huang, R.Y., Enarson, D.A. and Chiang, C.Y., 2014. Indoor air pollution from solid fuel and tuberculosis: a systematic review and meta-analysis. The International journal of tuberculosis and lung disease, 18(5), pp.613-621.
28. Lin, H.H., Wang, L., Zhang, H., Ruan, Y., Chin, D.P. and Dye, C., 2015. Tuberculosis control in China: use of modelling to develop targets and policies. Bulletin of the World Health Organization, 93, pp.790-798.
29. Lin, H.H., Wu, C.Y., Wang, C.H., Fu, H., Lönnroth, K., Chang, Y.C. and Huang, Y.T., 2018. Association of obesity, diabetes, and risk of tuberculosis: two population-based cohorts. Clinical Infectious Diseases, 66(5), pp.699-705.
30. Lin, S.P., Chen, I.C., Lin, C.H., Hsiao, T.H., Liu, P.Y. and Chen, Y.M., 2025. Host Genetic Factors and Clinical Comorbidities Associated With Tuberculosis Risk. HLA, 106(3), p.e70384.
31. Liu, Q., You, N., Wen, J., Wang, J., Ge, Y., Shen, Y., Ding, X., Lu, P., Chen, C., Zhu, B. and Zhu, L., 2023. Yield and efficiency of a population-based mass tuberculosis screening intervention among persons with diabetes in Jiangsu Province, China. Clinical Infectious Diseases, 77(1), pp.103-111.
32. Liu, A., Liao, Y., Ye, J., Wang, Q., Huang, J., Tang, Y., & Feng, L. (2026). Effect of Drug Cost-Exemption Policy on Treatment Outcomes in Multidrug-Resistant Tuberculosis Patients in Guangxi Zhuang Autonomous Region, China: A Nested Case–Control Study. ClinicoEconomics and Outcomes Research, 577874.
33. Liu, C.Y., Chen, R.T., Shu, C.C. and Lin, S.Y., 2025. Prevalence, clinical reasons and associated factors of extended treatment duration for drug susceptible tuberculosis–a real-world experience. Scientific Reports, 15(1), pp.1-8.
34. Liu, K.H., Xiao, Y.X. and Jou, R., 2024. Multidrug-resistant tuberculosis clusters and transmission in Taiwan: a population-based cohort study. Frontiers in Microbiology, 15, p.1439532.
35. Lo, H.Y., Yang, S.L., Lin, H.H., Bai, K.J., Lee, J.J., Lee, T.I. and Chiang, C.Y., 2016. Does enhanced diabetes management reduce the risk and improve the outcome of tuberculosis?. The International Journal of Tuberculosis and Lung Disease, 20(3), pp.376-382.
36. Lu, P., Zhang, Y., Liu, Q., Ding, X., Kong, W., Zhu, L. and Lu, W., 2021. Association of BMI, diabetes, and risk of tuberculosis: a population-based prospective cohort. International Journal of Infectious Diseases, 109, pp.168-173.
37. Lu, J.W., Mao, J.J., Zhang, R.R., Li, C.H., Sun, Y., Xu, W.Q., Zhuang, X., Zhang, B. and Qin, G., 2023. Association between long-term exposure to ambient air pollutants and the risk of tuberculosis: A time-series study in Nantong, China. Heliyon, 9(6).
38. Luo, D., Wang, F., Chen, S., Zhang, Y., Wang, W., Wu, Q., Ling, Y., Zhou, Y., Li, Y., Liu, K. and Chen, B., 2025. Application of the age-period-cohort model in tuberculosis. Frontiers in Public Health, 13, p.1486946.

Referensi Tuberkulosis D-F

 

1. d'Elbée, M., Harker, M., Mafirakureva, N., Nanfuka, M., Nguyet, M.H.T.N., Taguebue, J.V., Moh, R., Khosa, C., Mustapha, A., Mwanga-Amumpere, J. and Borand, L., 2024. Cost-effectiveness and budget impact of decentralising childhood tuberculosis diagnosis in six high tuberculosis incidence countries: a mathematical modelling study. EClinicalMedicine, 70, p.102528.
2. Dalimunthe, A., Sinaga, B.Y.M., Siagian, P. and Amelia, R., 2025. Social Support and Healthcare Service Quality as Determinants of Treatment Interruption Among Drug-Resistant Tuberculosis Patients in Medan, Indonesia. Jurnal Impresi Indonesia, 4(11), pp.5176-5183.
3. Dasan, B., Rajamanickam, A., Pandiarajan, A.N., Shanmugam, S., Nott, S. and Babu, S., 2025. Immunological mechanisms of tuberculosis susceptibility in TB-infected individuals with type 2 diabetes mellitus: insights from mycobacterial growth inhibition assay and cytokine analysis. Microbiology Spectrum, 13(1), pp.e01445-24.
4. Dewi, N.P.A.N. and Susilawati, N.M., 2024. Hubungan Pekerjaan dan Pendidikan dengan Kejadian TB Paru di Kota Kupang. Inovasi Kesehatan Global, 1(4), pp.139-148.
5. Dodd, P.J., Yuen, C.M., Jayasooriya, S.M., van der Zalm, M.M. and Seddon, J.A., 2021. Quantifying the global number of tuberculosis survivors: a modelling study. The Lancet Infectious Diseases, 21(7), pp.984-992.
6. Dos Santos, P.C.P., Messina, N.L., de Oliveira, R.D., da Silva, P.V., Puga, M.A.M., Dalcolmo, M., Dos Santos, G., de Lacerda, M.V.G., Jardim, B.A., e Val, F.F.D.A. and Curtis, N., 2024. Effect of BCG vaccination against Mycobacterium tuberculosis infection in adult Brazilian health-care workers: a nested clinical trial. The Lancet Infectious Diseases, 24(6), pp.594-601.
7. Dou, H. Y., Huang, T. S., Wu, H. C., Hsu, C. H., Chen, F. J., & Liao, Y. C. (2025). Targeted sputum sequencing for rapid and broad drug resistance of Mycobacterium tuberculosis. Infection, 53(4), 1413-1423.
8. Du, Z.X., Ren, Y.Y., Wang, J.L., Li, S.X., Hu, Y.F., Wang, L., Chen, M.Y., Li, Y., Hu, C.M. and Yang, Y.F., 2024. The potential association between metabolic disorders and pulmonary tuberculosis: a Mendelian randomization study. European Journal of Medical Research, 29(1), p.277.
9. Dwinata I, Tsheten T, Ansariadi A, Wagnew F, Alene KA, Sutarsa IN, Moraga P, Putra IW, Kelly M. Geospatial codistribution of tuberculosis and diabetes mellitus in Indonesia. Infectious Diseases of Poverty. 2026 Mar 30;15(1):37.
10. Dye, C., Garnett, G.P., Sleeman, K. and Williams, B.G., 1998. Prospects for worldwide tuberculosis control under the WHO DOTS strategy. The Lancet, 352(9144), pp.1886-1891.
11. Dye, C., Watt, C.J., Bleed, D.M., Hosseini, S.M. and Raviglione, M.C., 2005. Evolution of tuberculosis control and prospects for reducing tuberculosis incidence, prevalence, and deaths globally. Jama, 293(22), pp.2767-2775.
12. Eksa, D.R., Hendarto, G.S., Sinaga, F.T., Dilangga, P., Herdato, M.J.D., Infianto, A., Ekawati, D., Gozali, A. and Ajipurnomo, A., 2025. Comparative Diagnostic Accuracy of LF-LAM TB Antigen and Xpert MTB/RIF in Pulmonary Tuberculosis among Underweight Patients. Jurnal Respirologi Indonesia, 45(4), pp.272-279.
13. Eksombatchai, D., Jeong, D., Mok, J., Jeon, D., Kang, H.Y., Kim, H.J., Kim, H.S., Choi, H. and Kang, Y.A., 2023. Sex differences in the impact of diabetes mellitus on tuberculosis recurrence: a retrospective national cohort study. International Journal of Infectious Diseases, 127, pp.1-10.
14. Esmail, A., Randall, P., Oelofse, S. et al. Comparison of two diagnostic intervention packages for community-based active case finding for tuberculosis: an open-label randomized controlled trial. Nat Med 29, 1009–1016 (2023).
15. Evans, D., Hirasen, K., Casalme, D.J., Gler, M.T., Gupta, A. and Juneja, S., 2024. Cost and cost-effectiveness of BPaL regimen used in drug-resistant TB treatment in the Philippines. IJTLD open, 1(6), pp.242-249.
16. Fadhilah, A.N. and Wikandari, R.J., 2024. The relationship between the length of treatment for pulmonary tuberculosis patients in the intensive phase and hemoglobin levels. Journal of Indonesian Medical Laboratory and Science, 5(2), pp.140-149.
17. Fahdhienie, F., Mudatsir, M., Abidin, T.F. and Nurjannah, N., 2024. Risk factors of pulmonary tuberculosis in Indonesia: a case-control study in a high disease prevalence region. Narra J, 4(2), p.e943.
18. Fitri, V.K., Zaman, C., Priyanto, A.D. and Ekawati, D., 2025. Analysis Factor of Compliance With Taking Anti-Pulmonary Tuberculosis Drugs in Patients With Pulmonary Tuberculosis. Lentera Perawat, 6(1), pp.59-68.
19. Foster, N., Cunnama, L., McCarthy, K., Ramma, L., Siapka, M., Sinanovic, E., Churchyard, G., Fielding, K., Grant, A.D. and Cleary, S., 2021. Strengthening health systems to improve the value of tuberculosis diagnostics in South Africa: A cost and cost-effectiveness analysis. Plos one, 16(5), p.e0251547.
20. Franco, J.V., Bongaerts, B., Metzendorf, M.I., Risso, A., Guo, Y., Silva, L.P., Boeckmann, M., Schlesinger, S., Damen, J.A., Richter, B. and Baddeley, A., 2024. Diabetes as a risk factor for tuberculosis disease. The Cochrane database of systematic reviews, 8, p.CD016013.
21. Franke, M.A., Emmrich, J.V., Ranjaharinony, F., Ravololohanitra, O.G., Andriamasy, H.E., Knauss, S. and Muller, N., 2024. A cross-sectional analysis of the effectiveness of a nutritional support programme for people with tuberculosis in Southern Madagascar using secondary data from a non-governmental organisation. Infectious Diseases of Poverty, 13(1), p.13.
22. Fu, H., Lin, H.H., Hallett, T.B. and Arinaminpathy, N., 2018. Modelling the effect of discontinuing universal Bacillus Calmette-Guérin vaccination in an intermediate tuberculosis burden setting. Vaccine, 36(39), pp.5902-5909.
23. Fu, H., Lin, HH., Hallett, T.B. et al. Explaining age disparities in tuberculosis burden in Taiwan: a modelling study. BMC Infect Dis 20, 191 (2020). https://doi.org/10.1186/s12879-020-4914-2
24. Fuady, A., Hutanamon, T., Herlinda, O., Luntungan, N. and Wingfield, T., 2024. Achieving universal social protection for people with tuberculosis. The Lancet Public Health, 9(5), pp.e339-e344.
25. Furin, J., Cox, H., & Pai, M. (2019). Tuberculosis. Lancet (London, England), 393(10181), 1642–1656.